CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- 10-K Report Annual Report
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Medical Officer and SVP gave up 4,823 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, GC and Corporate Affairs gave up 2,012 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes SVP and CFO gave up 2,170 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 2,710 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Commercial Operations gave up 2,395 shares (to pay taxes)
- EFFECT Other Notice of Effectiveness
- 424B5 Offering Prospectus
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations · Regulation FD disclosure
Page 29 of 38 · 742 filings